Researchers have demonstrated that Nafamostat mesylate (Fusan) can inhibit SARS-CoV-2 Spike protein-initiated membrane fusion at concentrations likely achievable and safe in patients.
List view / Grid view
University of Tokyo
Filter the results
In a recent study in mice, researchers have found a way to deliver specific drugs to parts of the body that are exceptionally difficult to access.
Researchers collaborated to identify the clearest image of the Ebola virus protein ever obtained using a cryo-electron microscope...